Works matching IS 14783223 AND DT 2024 AND VI 44 AND IP 7

Results: 25

Sex differences in mortality and liver-related events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1600, doi. 10.1111/liv.15910

By:

Huimin Zhou;
Haiyan Chen;
Hanxiao Lu;
Bo Wu;
Shuo Zhang;
Yuanlong Gu;
Guangwen Zhou;
Jie Xiang;
Jun Yang

Publication type:

Article

Neurokinin-1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS/JNK in intrahepatic cholangiocarcinoma.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1651, doi. 10.1111/liv.15904

By:

Yang Yang;
Xueyan Cao;
Yuting Wang;
Xinyu Wu;
Ping Zhou;
Lin Miao;
Xueting Deng

Publication type:

Article

Estimating the prevalence of hepatitis delta virus infection among adults in the United States: A meta-analysis.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1715, doi. 10.1111/liv.15921

By:

Wong, Robert J.;
Brosgart, Carol;
Wong, Steven S.;
Feld, Jordan;
Glenn, Jeffrey;
Hamid, Saeed;
Cohen, Chari;
Zovich, Beatrice;
Ward, John;
Wedemeyer, Heiner;
Yurdaydin, Cihan;
Gish, Robert

Publication type:

Article

Reply to the letter 'Preoperative MRI in predicting tumour recurrence of hepatocellular carcinoma: Does AI have a role?'.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1738, doi. 10.1111/liv.15957

By:

Fang Wang;
Qing-Qing Chen;
Hong-Jie Hu

Publication type:

Article

Histological characterization of liver involvement in systemic mastocytosis.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1680, doi. 10.1111/liv.15913

By:

Rossignol, Julien;
Canioni, Danielle;
Aouba, Achille;
Bulai-Livideanu, Cristina;
Barete, Stéphane;
Lancesseur, Charles;
Polivka, Laura;
Madrange, Marine;
Ballul, Thomas;
Neuraz, Antoine;
Greco, Celine;
Agopian, Julie;
Brenet, Fabienne;
Dubreuil, Patrice;
Lemal, Richard;
Tournilhac, Olivier;
Terriou, Louis;
Launay, David;
Bouillet, Laurence;
Gourguechon, Clément

Publication type:

Article

Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver transplantation.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1483, doi. 10.1111/liv.15917

By:

Reichelt, Sophie;
Merle, Uta;
Klauss, Miriam;
Kahlert, Christoph;
Lurje, Georg;
Mehrabi, Arianeb;
Czigany, Zoltan

Publication type:

Article

The first MASH drug therapy on the horizon: Current perspectives of resmetirom.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1526, doi. 10.1111/liv.15930

By:

Petta, Salvatore;
Targher, Giovanni;
Romeo, Stefano;
Pajvani, Utpal B.;
Ming-Hua Zheng;
Aghemo, Alessio;
Valenti, Luca V. C.

Publication type:

Article

MAFLD predicts cardiovascular disease risk better than MASLD.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1567, doi. 10.1111/liv.15931

By:

Ziyan Pan;
Shiha, Gamal;
Esmat, Gamal;
Méndez-Sánchez, Nahum;
Eslam, Mohammed

Publication type:

Article

Bringing evidence to the MAFLD- MASLD debate.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1740, doi. 10.1111/liv.16000

By:

Ziyan Pan;
Eslam, Mohammed

Publication type:

Article

Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1513, doi. 10.1111/liv.15925

By:

Mantovani, Alessandro;
Lando, Maria Giovanna;
Borella, Nicolò;
Scoccia, Enrico;
Pecoraro, Barbara;
Gobbi, Federico;
Bisoffi, Zeno;
Valenti, Luca;
Tilg, Herbert;
Byrne, Christopher D.;
Targher, Giovanni

Publication type:

Article

FGF21 protects against ischaemia reperfusion injury in normal and fatty livers.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1668, doi. 10.1111/liv.15911

By:

Yong Ma;
Singhal, Garima;
Chan, Suzanne S.;
Chaoqun Wang;
Hongjun Yu;
Bing Yin;
Jing Pang;
Malvar, Grace;
Nasser, Imad;
Mather, Marie L.;
Maratos-Flier, Eleftheria

Publication type:

Article

ENPP2/Autotaxin: The potential drug target for alcoholic liver disease identified through Mendelian randomization analysis.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1624, doi. 10.1111/liv.15905

By:

Peiqiong Luo;
Xuefeng Yu

Publication type:

Article

Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction-associated steatotic liver disease.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1700, doi. 10.1111/liv.15920

By:

Takashi Kumada;
Hidenori Toyoda;
Sadanobu Ogawa;
Tatsuya Gotoh;
Yasuaki Suzuki;
Katsutoshi Sugimoto;
Yuichi Yoshida;
Hidekatsu Kuroda;
Yoshihiro Kamada;
Yoshio Sumidad;
Takanori Ito;
Tomoyuki Akita;
Junko Tanaka

Publication type:

Article

Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".

Published in:

Liver International, 2024, v. 44, n. 7, p. 1736, doi. 10.1111/liv.15964

By:

Tatsuya Kikuchi;
Yasuto Takeuchi;
Kazuhiro Nouso;
Kazuya Kariyama;
Kenji Kuwaki;
Junichi Toshimori;
Shota Iwado;
Akio Moriya;
Hiroaki Hagihara;
Hiroyuki Takabatake;
Toshifumi Tada;
Tetsuya Yasunaka;
Masahiro Sakata;
Masahiko Sue;
Nozomi Miyake;
Takuya Adachi;
Nozomu Wada;
Hideki Onishi;
Hidenori Shiraha;
Akinobu Takaki

Publication type:

Article

Preoperative MRI in predicting tumour recurrence of hepatocellular carcinoma: Does AI have a role?

Published in:

Liver International, 2024, v. 44, n. 7, p. 1739, doi. 10.1111/liv.15929

By:

Teh- Ia Huo;
Shu- Yein Ho

Publication type:

Article

Excessive fatty acids activate PRMT5/MDM2/Drosha pathway to regulate miRNA biogenesis and lipid metabolism.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1634, doi. 10.1111/liv.15906

By:

Aijun Hou;
Xiaoding Xu;
Yu Zhang;
Hongxiu He;
Yihan Feng;
Wenhui Fan;
Rongrong Tan;
Likun Gong;
Jing Chen

Publication type:

Article

Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14414 patients.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1689, doi. 10.1111/liv.15919

By:

Hegmar, Hannes;
Wester, Axel;
Aleman, Soo;
Backman, Jens;
Degerman, Erik;
Ekvall, Håkan;
Lund, Katarina;
Lundgren, Åsa;
Nasr, Patrik;
Shahnavaz, Afshin;
Vessby, Johan;
Westin, Johan;
Önnerhag, Kristina;
Hagström, Hannes

Publication type:

Article

Using GPT-4 for LI-RADS feature extraction and categorization with multilingual free-text reports.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1578, doi. 10.1111/liv.15891

By:

Kyowon Gu;
Jeong Hyun Lee;
Jaeseung Shin;
Jeong Ah Hwang;
Ji Hye Min;
Woo Kyoung Jeong;
Min Woo Lee;
Kyoung Doo Song;
Sung Hwan Bae

Publication type:

Article

Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1588, doi. 10.1111/liv.15855

By:

Giannini, Edoardo G.;
Pasta, Andrea;
Pieri, Giulia;
Plaz Torres, Maria Corina;
Marseglia, Mariarosaria;
Pelizzaro, Filippo;
Sangiovanni, Angelo;
Cabibbo, Giuseppe;
Ghittoni, Giorgia;
Di Marco, Mariella;
Foschi, Francesco Giuseppe;
Guarino, Maria;
Biasini, Elisabetta;
Saitta, Carlo;
Campani, Claudia;
Svegliati-Baroni, Gianluca;
Gasbarrini, Antonio;
Brunetto, Maurizia Rossana;
Magalotti, Donatella;
Azzaroli, Francesco

Publication type:

Article

Advancing radiology reporting with large language models: Is GPT- 4 the LI- RADS game changer or just a wild card?

Published in:

Liver International, 2024, v. 44, n. 7, p. 1575, doi. 10.1111/liv.15952

By:

Díaz González, Álvaro;
Forner, Alejandro;
Turnes, Juan

Publication type:

Article

Prevalence of HCV infection in Europe in the DAA era: Review.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1548, doi. 10.1111/liv.15981

By:

D'Ambrosio, Roberta;
Anolli, Maria P.;
Pugliese, Nicola;
Masetti, Chiara;
Aghemo, Alessio;
Lampertico, Pietro

Publication type:

Article

The MAFLD- MASLD debate: Does cardiovascular risk prediction define the winner?

Published in:

Liver International, 2024, v. 44, n. 7, p. 1564, doi. 10.1111/liv.15950

By:

Ciardullo, Stefano

Publication type:

Article

Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1735, doi. 10.1111/liv.15944

By:

Bing Chen;
Bojie Huang

Publication type:

Article

Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1610, doi. 10.1111/liv.15889

By:

Campello, Elena;
Zanetto, Alberto;
Radu, Claudia M.;
Toffanin, Serena;
Shalaby, Sarah;
Gavasso, Sabrina;
Rizzo, Stefania;
Perin, Nicola;
Angeli, Paolo;
Burra, Patrizia;
Senzolo, Marco;
Simioni, Paolo

Publication type:

Article

Changing landscape of alcohol-associated liver disease in younger individuals, women, and ethnic minorities.

Published in:

Liver International, 2024, v. 44, n. 7, p. 1537, doi. 10.1111/liv.15933

By:

Arab, Juan P.;
Dunn, Winston;
Im, Gene;
Singal, Ashwani K.

Publication type:

Article